Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Teriparatide injection - Asahi Kasei Pharma

Next Previous
Drug Profile

Teriparatide injection - Asahi Kasei Pharma

Alternative Names: hPTH - Asahi Kasei Pharma; MN-10-T; PTH injection - Asahi Kasei Pharma; Teribone

Latest Information Update: 14 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Asahi Kasei Pharma Corp
  • Developer Asahi Kasei Pharma Corp; Dong-A ST
  • Class Diagnostic agents; Osteoporosis therapies; Peptide hormones; Skin disorder therapies
  • Mechanism of Action Parathyroid hormone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Osteoporosis

Most Recent Events

  • 21 Oct 2025 Asahi Kasei has patent protection for Teriparatide injection in Japan
  • 21 Oct 2025 ntellectual Property High Court accepts the settlement in a patent infringement lawsuit filed against Sawai Pharmaceutical by Asahi Kasei Pharma for unauthorized manufacture and sale of a generic teriparatide product in Japan
  • 31 Mar 2020 Nagasaki University Hospital completes a clinical trial for Osteoporosis (In the elderly) in Japan (UMIN000020584)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top